These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 16043512)

  • 21. Loss of Tsc1/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR.
    Zhang H; Cicchetti G; Onda H; Koon HB; Asrican K; Bajraszewski N; Vazquez F; Carpenter CL; Kwiatkowski DJ
    J Clin Invest; 2003 Oct; 112(8):1223-33. PubMed ID: 14561707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2.
    Garami A; Zwartkruis FJ; Nobukuni T; Joaquin M; Roccio M; Stocker H; Kozma SC; Hafen E; Bos JL; Thomas G
    Mol Cell; 2003 Jun; 11(6):1457-66. PubMed ID: 12820960
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phosphorylation and binding partner analysis of the TSC1-TSC2 complex.
    Nellist M; Burgers PC; van den Ouweland AM; Halley DJ; Luider TM
    Biochem Biophys Res Commun; 2005 Aug; 333(3):818-26. PubMed ID: 15963462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TSC1 and TSC2 regulate cilia length and canonical Hedgehog signaling via different mechanisms.
    Rosengren T; Larsen LJ; Pedersen LB; Christensen ST; Møller LB
    Cell Mol Life Sci; 2018 Jul; 75(14):2663-2680. PubMed ID: 29396625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drosophila Tsc1 functions with Tsc2 to antagonize insulin signaling in regulating cell growth, cell proliferation, and organ size.
    Potter CJ; Huang H; Xu T
    Cell; 2001 May; 105(3):357-68. PubMed ID: 11348592
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polymerized collagen inhibits fibroblast proliferation via a mechanism involving the formation of a beta1 integrin-protein phosphatase 2A-tuberous sclerosis complex 2 complex that suppresses S6K1 activity.
    Xia H; Nho R; Kleidon J; Kahm J; Henke CA
    J Biol Chem; 2008 Jul; 283(29):20350-60. PubMed ID: 18487611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuromuscular abundance of RB1CC1 contributes to the non-proliferating enlarged cell phenotype through both RB1 maintenance and TSC1 degradation.
    Chano T; Saji M; Inoue H; Minami K; Kobayashi T; Hino O; Okabe H
    Int J Mol Med; 2006 Sep; 18(3):425-32. PubMed ID: 16865226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Negative regulation of TSC1-TSC2 by mammalian D-type cyclins.
    Zacharek SJ; Xiong Y; Shumway SD
    Cancer Res; 2005 Dec; 65(24):11354-60. PubMed ID: 16357142
    [TBL] [Abstract][Full Text] [Related]  

  • 29. VPS34 regulates TSC1/TSC2 heterodimer to mediate RheB and mTORC1/S6K1 activation and cellular transformation.
    Mohan N; Shen Y; Dokmanovic M; Endo Y; Hirsch DS; Wu WJ
    Oncotarget; 2016 Aug; 7(32):52239-52254. PubMed ID: 27409169
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of the TSC1-TSC2 complex in the integration of insulin and glucose signaling involved in pancreatic beta-cell proliferation.
    Bartolomé A; Guillén C; Benito M
    Endocrinology; 2010 Jul; 151(7):3084-94. PubMed ID: 20427478
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growth signaling: TSC takes its place.
    Marygold SJ; Leevers SJ
    Curr Biol; 2002 Nov; 12(22):R785-7. PubMed ID: 12445406
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of mTOR and cell growth in response to energy stress by REDD1.
    Sofer A; Lei K; Johannessen CM; Ellisen LW
    Mol Cell Biol; 2005 Jul; 25(14):5834-45. PubMed ID: 15988001
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tsc tumour suppressor proteins antagonize amino-acid-TOR signalling.
    Gao X; Zhang Y; Arrazola P; Hino O; Kobayashi T; Yeung RS; Ru B; Pan D
    Nat Cell Biol; 2002 Sep; 4(9):699-704. PubMed ID: 12172555
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis.
    Ma L; Chen Z; Erdjument-Bromage H; Tempst P; Pandolfi PP
    Cell; 2005 Apr; 121(2):179-93. PubMed ID: 15851026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase.
    Roux PP; Ballif BA; Anjum R; Gygi SP; Blenis J
    Proc Natl Acad Sci U S A; 2004 Sep; 101(37):13489-94. PubMed ID: 15342917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional assessment of TSC2 variants identified in individuals with tuberous sclerosis complex.
    Hoogeveen-Westerveld M; Ekong R; Povey S; Mayer K; Lannoy N; Elmslie F; Bebin M; Dies K; Thompson C; Sparagana SP; Davies P; van Eeghen AM; Thiele EA; van den Ouweland A; Halley D; Nellist M
    Hum Mutat; 2013 Jan; 34(1):167-75. PubMed ID: 22903760
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TSC1 and TSC2: genes that are mutated in the human genetic disorder tuberous sclerosis.
    Sampson JR
    Biochem Soc Trans; 2003 Jun; 31(Pt 3):592-6. PubMed ID: 12773162
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TSC2 mediates cellular energy response to control cell growth and survival.
    Inoki K; Zhu T; Guan KL
    Cell; 2003 Nov; 115(5):577-90. PubMed ID: 14651849
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The variation of AkT/TSC1-TSC1/mTOR signal pathway in hepatocytes after partial hepatectomy in rats.
    Chen P; Yan H; Chen Y; He Z
    Exp Mol Pathol; 2009 Apr; 86(2):101-7. PubMed ID: 19348060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor suppressor Tsc1 is a new Hsp90 co-chaperone that facilitates folding of kinase and non-kinase clients.
    Woodford MR; Sager RA; Marris E; Dunn DM; Blanden AR; Murphy RL; Rensing N; Shapiro O; Panaretou B; Prodromou C; Loh SN; Gutmann DH; Bourboulia D; Bratslavsky G; Wong M; Mollapour M
    EMBO J; 2017 Dec; 36(24):3650-3665. PubMed ID: 29127155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.